The elusive nature of cerebellar somatostatin receptors: Studies in rat, monkey and human cerebellum

Journal of Receptor and Signal Transduction Research

Volumn 17, Issue 1-3, 1997, Pages 385-405

  Piwko, Charles ^b   Thoss, V Silke ^b   Probst, Alphonse ^b   Hoyer, Daniel ^a  

^a Preclinical Research   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN RECEPTOR; RECEPTOR SUBTYPE; SOMATOSTATIN RECEPTOR;

ANIMAL TISSUE; CEREBELLUM; CONFERENCE PAPER; DENTATE NUCLEUS; HUMAN; HUMAN TISSUE; ISOTOPE LABELING; LIGAND BINDING; MALE; NONHUMAN; PROTEIN ANALYSIS; RAT; RECEPTOR BINDING; RHESUS MONKEY; SPECIES DIFFERENCE; TISSUE DISTRIBUTION;

EID: 0031016352     PISSN: 10799893     EISSN: None     Source Type: Journal    
DOI: 10.3109/10799899709036616     Document Type: Conference Paper

References (40)

1. Reichlin, S. Somatostatin. N. Engl. J. Med. 309, 1495-1505, 1556-1563, 1983
2. Epelbaum, J.; Dournaud, P.; Fodor, M.; and Viollet, C. The neurobiology of somatostatin. critical Reviews Neurobiology 8, 25-44, 1994
3. Leroux, P.; Bodenant, C.; Bologna, E.; Gonzalez, B. J.; and Vaudry, H. Transient expression of somatostatin receptors in the brain during development. in Somatostatin and its Receptors, Ciba Foundation Symposium 190, edited by D. J. Chadwick and G. Cardew, p. 127-137, John Wiley & Sons, Chichester, 1995
4. Koch, B. D.; Dorflinger, L. J.; and Schonbrunn, A. Pertussis toxin blocks both cyclic AMP-mediated and cyclic AMP-independent action of somatostatin. J.Biol. Chem. 260, 13138-13145, 1985
5. Kaupmann, K.; Bruns, C.; Hoyer, D.; Seuwen, K.; and Lübbert, H. Distribution and second messenger coupling of four somatostatin receptor subtypes expressed in brain. FEBS Lett. 331, 53-59, 1993
6. Hoyer, D.; Lübbert, H.; and Bruns, C. Molecular pharmacology of somatostatin receptors. Naunyn Schmiedeberg's Arch. Pharmacol. 350, 441-453, 1994
7. Bell, G. I.; and Reisine, T. Molecular biology of somatostatin receptors. TiNS 16, 34-38, 1993
8. Hoyer, D.; Bell, G. I.; Berelowitz, M.; Epelbaum, J.; Feniuk, W.; Humphrey, P. P. A.; O'Carroll, A. M.; Patel, Y. C.; Schonbrunn, A.; Taylor, J. E; and Reisine, T. Classification and nomenclature of somatostatin receptors. TiPS 16, 86-88, 1995
9. Patel, Y.; Rao, K.; and Reichlin, S. Somatostatin in human cerebrospinal fluid. New Engl. J. Med. 296, 529-533, 1977
10. Davies, P.; Katzman, R.; and Terry, R. D. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementia. Nature 288, 279-280, 1994
11. Beal, M. F.; Bird, E. D.; Langlais, P. J.; and Martin, J. B. Somatostatin is increased in the nucleus accumbens in Huntington's disease. Neurology 34, 663-666, 1984
12. Nemeroff, C. B.; Youngblood, W. W.; Manberg, P. J.; Prange, A. J.(Jr.); and Kizer, J. S. Regional brain concentration of neuropeptides in Huntington's chorea and schizophrenia. Science 221, 972-975, 1983
13. Sorensen, K. V.; Christensen, S. E.; Dupont, E.; Hansen, A. P.; Pedersen, E.; and Orskov, H. Low somatostatin content in cerebrospinal fluid in multiple sclerosis. Acta Neurol. 61, 186-191, 1980
14. Ferner, I. N.; Roberts, G. W.; Crow, T. J.; Johnstone, E. C.; Owens, D. G.; Lee, Y. C.; O'Shaughnessy, D.; Adrian, T. E.; Polak, J. M.; and Bloom, S. R. Reduced cholecystokinin-like immunoreactivity and somatostatin-like immunoreactivity in limbic lobe is associated with negative symptoms in schizophrenia. Life Sci. 33, 475-482, 1983
15. Rubinow, D. R.; Gold, P. W.; Post, R. M.; and Ballenger, J. C. CSF Somatostatin in affective illness. Archs. Gen. Psychiat. 40, 409-412, 1983
16. Epelbaum, J.; Ruberg, M.; Moyse, E.; Javoy-Agid, B.; Dubois, B.; and Agid, Y. Somatostatin and dementia in Parkinson's disease. Brain Res. 278, 376-379, 1983
17. Beal, M. F.; Mazurek, M. F.; Black, P. McL.; and Martin, J. B. Human cerebrospinal fluid somatostatin in neurological disease. J. Neurol. Sci. 71, 91-104, 1985
18. Gonzalez, B.; Leroux, P.; Lamacz, M.; Bodenant, C.; Balazs, R.; and Vaudry, H. Somatostatin receptors are expressed by immature cerebellar granule cells: Evidence for a direct inhibitory effect of somatostatin on neuroblast activity. Proc. Natl. Acad. Sci. USA. 89, 9627-9631, 1992
19. Reubi, J. C.; Cortès, R.; Maurer, R.; Probst, A.; and Palacios, J. M. Distribution of somatostatin receptors in the human brain, an autoradiographic study. Neuroscience 18, 329-346, 1986
20. Laquerrière, A.; Leroux, P.; Bodenant, C.; Gonzalez, B. J.; Tajot, J.; and Vaudry, H. Quantitative autoradiographic study of somatostatin receptors in the adult human cerebellum. Neuroscience 62, 1147-1154, 1994
21. Laquerrière, A.; Leroux, P.; Gonzalez, B. J.; Bodenant, C.; Tajot, J.; and Vaudry, H. Somatostatin receptors in the human cerebellum during development. Brain Res. 573, 251-259, 1992
22. Schoeffter, P.; Pérez, J.; Langenegger, D.; Schüpbach, E.; Lübbert, H.; Bruns, C.; and Hoyer, D. Characterization and distribution of somatostatin SS-1 and SRIF-1 binding sites in rat brain: identity with SSTR-2 receptors. Eur. J. Pharmacol. Mol. Pharmacol. Section 289, 163-173, 1995
23. Martin, J. L.; Chesselet, M. F.; Raynor, K.; Gonzales, C.; and Reisine, T. Differential distribution of somatostatin receptor subtypes in rat brain revealed by newly developed somatostatin analogs. Neuroscience 41, 581-593, 1991
24. Raynor, K.; O'Carroll, A. M.; Kong, H.; Yasuda, K.; Mahan, L. C.; Bell, G. I.; and Reisine, T. Characterization of cloned somatostatin receptors. Mol Pharmacol. 44, 385-392, 1993
25. Raynor, K.; Murphy, W. A.; Coy, D. H.; Taylor, J. E.; Moreau, J. P.; Yasuda, K.; Bell, G. I.; and Reisine, T. Cloned somatostatin receptors: Identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides. Mol. Pharmacol. 43, 838-844, 1993
26. Reubi, J. C.; and Maurer, R. Different ionic requirements for somatostatin receptor subpopulation in the brain. Reg. Pep. 14, 301-311, 1986
27. Thoss, V. S.; Piwko, C.; and Hoyer, D. Somatostatin receptors in the Rhesus monkey brain: localization and pharmacological characterization. Naunyn-Schmiedeberg's Arch. Pharmacol. In press, 1996
28. Pazos, A.; Hoyer, D.; and Palacios, J. M. The binding of serotonergic ligand to the porcine choroid plexus: characterization of a new type of serotonin recognition site. Eur. J. Pharmacol. 106, 539-546, 1984
29. 3H]ketanserin. Eur. J. Pharmacol. 18, 13-23, 1985
30. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254, 1976
31. Pérez, J.; Rigo, M.; Kaupmann, K.; Bruns, C.; Yasuda, K.; Bell, G. I.; Lübbert, H.; Hoyer, D. Localization of somatostatin (SRIF) SSTR-1, SSTR-2 and SSTR-3 receptor mRNA in rat brain by in situ hybridization. Naunyn Schmiedeberg's Arch. Pharmacol. 349, 145-160, 1994
32. Pérez, J.; and Hoyer, D. Coexpression of somatostatin SSTR-4 and SSTR-3 receptor mRNAs in the rat central nervous system. Neuroscience 64, 241-253, 1995
33. Thoss, V. S.; Pérez, J.; Duc, D.; and Hoyer, D. Embryonic and postnatal mRNA distribution of five receptor subtypes in the rat brain. Neuropharmacology 34, 1673-1688, 1995
34. Thoss, V. S.; Pérez, J.; Probst, A.; and Hoyer, D. Expression of five somatostatin receptor mRNAs in the human brain and pituitary. Naunyn-Schmiedeberg's Arch. Pharmacol. submitted
35. Hoyer, D.; Pérez, J.; Schoeffter, P.; Langenegger, D.; Schüpbach, E.; Kaupmann, K.; Lübbert, H.; Bruns, C.; and Reubi, J. C. Pharmacological identity between somatostatin SS-2 binding sites and SSTR-1 receptors. Eur. J. Pharmacol., Mol. Pharmacol. Section 289, 151-161, 1995
36. 1-5). Endocrinology 135, 2814-2817, 1994
37. Reubi, J. C. New specific radioligand for one subpopulation of brain somatostatin receptors. Life Sci. 36, 1829-1836, 1985
38. Bucharles, C.; Vaudry, H.; and Leroux, P. Pharmacological characterization of somatostatin receptors in rat cerebellar nuclei. Eur. J. Pharmacol. 271, 79-86, 1994
39. 2 sites in the rat cerebellum. Naunyn-Schmiedeberg's Arch. Pharmacol. 352, 607-613, 1995
40. 2 sites in the human cerebellum. Neuropharmacology, 1996, in press.